Finance

Lists
XNCR:NASDAQ
Xencor Inc
$26.65
+0.11%
(+0.030) 1D
Sep 4, 2:49:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XNCR...
Open
$26.05
High
$26.76
Low
$25.40
Mkt. cap
1.98B
Avg. vol.
1.27M
Volume
474.09K
52-wk high
$30.60
52-wk low
$8.19
EPS
-$2.17
Beta
0.88
Shares outstanding
74.35M
No. of employees
260
Open
$26.05
High
$26.76
Low
$25.40
Mkt. cap
1.98B
Avg. vol.
1.27M
Volume
474.09K
52-wk high
$30.60
52-wk low
$8.19
EPS
-$2.17
Beta
0.88
Shares outstanding
74.35M
No. of employees
260
News stories
From web sources and news partners
About Xencor Inc
CEO-
Employees260
Founded1997
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitexencor.com
Analyst ratings
Based on 12 analysts giving stock ratings to XNCR in the past 3 months
Strong buy
Buy
10
Hold
2
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for XNCR in the last 3 months.
Highest
Current $26.65
$46.00 (+72.61%)
Average
$31.00 (+16.32%)
Lowest
$20.00 (-24.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Hold
Maintained
$21.00
-21.2%
09/03/2026
Sean McCutcheon
Raymond James
Buy
Reiterated
$46.00
+72.6%
09/01/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$44.00
+65.1%
08/10/2026
Alec Stranahan
Bank of America Securities
Hold
Reiterated
$20.00
-25%
08/07/2026
Gregory Renza
Truist Financial
Buy
Reiterated
-
-
08/06/2026
John Newman
Canaccord Genuity
Buy
Maintained
$38.00
+42.6%
08/05/2026
David Nierengarten
Wedbush
Buy
Maintained
$30.00
+12.6%
08/06/2026
Leonid Timashev
RBC Capital
Buy
Maintained
$20.00
-25%
08/05/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$33.00
+23.8%
08/06/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
08/05/2026
Etzer Darout
Barclays
Buy
Maintained
$27.00
+1.3%
08/06/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
08/06/2026
Unknown Analyst
Wedbush
Buy
Maintained
$26.00
-2.4%
07/30/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$27.00
+1.3%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
21.00M
28.24M
4.52M
51.22M
Cost of goods sold
54.37M
64.82M
64.67M
71.90M
Cost of revenue
54.37M
64.82M
64.67M
71.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.15M
17.04M
17.71M
16.38M
Operating expense
14.15M
17.04M
17.71M
16.38M
Total operating expenses
68.52M
81.86M
82.38M
88.29M
Operating income
-47.52M
-53.63M
-77.86M
-37.07M
Other non operating income
-17.00K
-8.00K
396.00K
434.00K
EBT including unusual items
-6.03M
-4.27M
-128.64M
-21.92M
EBT excluding unusual items
-48.66M
-54.79M
-76.71M
-39.19M
Income tax expense
-
2.39M
280.00K
-190.00K
Effective tax rate
-
-55.95%
-0.22%
0.87%
Other operating expenses
-
-
-
-
Net income
-6.03M
-6.65M
-128.92M
-21.73M
Net profit margin
-28.70%
-23.56%
-2,854.65%
-42.42%
Earnings per share
-0.08
-0.09
-1.71
-0.29
Interest and investment income
6.54M
6.20M
5.46M
4.80M
Interest expense
-7.66M
-7.35M
-4.70M
-7.35M
Net interest expenses
-1.13M
-1.15M
759.00K
-2.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.93M
-51.05M
-75.30M
-34.63M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps